Precision BioSciences, Inc.
Price Action
Technical Summary
EMERGING TRENDPrecision BioSciences, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 86), indicating clear outperformance against the broad market. Earnings growth of 67% provides fundamental context to the price action. Investors should exercise caution due to high volatility (68% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.61 | +10.27% | ABOVE |
| 50 SMA | $7.11 | +2.55% | ABOVE |
| 100 SMA | $6.16 | +18.29% | ABOVE |
| 150 SMA | $5.60 | +30.16% | ABOVE |
| 200 SMA | $5.69 | +28.04% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is DTIL in an uptrend right now?
DTIL has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is DTIL overbought or oversold?
DTIL's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is DTIL outperforming the market?
DTIL has a Relative Strength (RS) Rating of 86 out of 99. Yes, DTIL is a market leader, outperforming 86% of all stocks over the past 12 months.
Where is DTIL in its 52-week range?
DTIL is trading at $7.29, which is 83% of its 52-week high ($8.82) and 71% above its 52-week low ($3.53).
How volatile is DTIL?
DTIL has a Beta of 1.16 and 52-week volatility of 68%. It's more volatile than the S&P 500 - expect bigger swings.